Chemistry:Afloqualone

From HandWiki
Short description: Chemical compound
Afloqualone
Afloqualone.svg
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
  • none
Legal status
Legal status
  • US: Unscheduled
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC16H14FN3O
Molar mass283.3 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Afloqualone (Arofuto) is a quinazolinone family GABAergic drug and is an analogue of methaqualone developed in the 1970s by a team at Tanabe Seiyaku.[1] It has sedative and muscle-relaxant effects resulting from its agonist activity at the β subtype of the GABAa receptor[2] and has had some clinical use, although it causes photosensitization as a side-effect that can cause skin problems such as dermatitis.[3]

See also

References

  1. Inoue I, Oine T, Yamada Y, Tani J, Ishida R, Ochiai T, "2-Fluoromethyl-3-o-tolyl-6-amino-4(3H)-quinazolinone", US patent 3966731, issued 29 June 1976, assigned to Tanabe Seiyaku Co Ltd
  2. "Pharmacological studies on 6-amino-2-fluoromethyl-3-(O-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity". Japanese Journal of Pharmacology 32 (3): 427–38. June 1982. doi:10.1254/jjp.32.427. PMID 7109348. 
  3. "Photoleukomelanodermatitis (Kobori) induced by afloqualone". The Journal of Dermatology 21 (6): 430–3. June 1994. doi:10.1111/j.1346-8138.1994.tb01768.x. PMID 8064007.